These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9635542)

  • 41. Comment on "what happened to lithium?: antidepressant augmentation in clinical settings".
    Terao T
    Am J Psychiatry; 2006 Dec; 163(12):2196-7; author reply 2197. PubMed ID: 17151180
    [No Abstract]   [Full Text] [Related]  

  • 42. Anxiolytic antidepressant augmentation.
    Sussman N
    J Clin Psychiatry; 1998; 59 Suppl 5():42-8; discussion 49-50. PubMed ID: 9635547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Augmentation strategies: focus on anxiolytics.
    Joffe RT; Levitt AJ; Sokolov ST
    J Clin Psychiatry; 1996; 57 Suppl 7():25-31; discussion 32-3. PubMed ID: 8690693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Commentary on the paper of Smith, et al.
    Angst J
    J Psychopharmacol; 2008 Jun; 22(4):404-5; discussion 408. PubMed ID: 18635718
    [No Abstract]   [Full Text] [Related]  

  • 46. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
    Artigas F
    Arch Gen Psychiatry; 1995 Nov; 52(11):969-71. PubMed ID: 7487345
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    Tijdschr Psychiatr; 2006; 48(4):271-81. PubMed ID: 16955991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapy refractory depression].
    Hatzinger M; Holsboer-Trachsler E
    Wien Med Wochenschr; 1999; 149(18):511-4. PubMed ID: 10637955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pindolol augmentation of antidepressant therapy.
    McAskill R; Mir S; Taylor D
    Br J Psychiatry; 1998 Sep; 173():203-8. PubMed ID: 9926094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The broad spectrum of bipolar disorder: implications for research and practice -- a commentary.
    Young AH
    J Psychopharmacol; 2008 Jun; 22(4):401; discussion 408. PubMed ID: 18635716
    [No Abstract]   [Full Text] [Related]  

  • 52. Overcoming the current approach in bipolar disorder research: towards DSM-V and beyond.
    Vieta E
    J Psychopharmacol; 2008 Jun; 22(4):406-7; discussion 408. PubMed ID: 18635719
    [No Abstract]   [Full Text] [Related]  

  • 53. Adding lithium to antidepressant therapy: factors related to therapeutic potentiation.
    Rybakowski J; Matkowski K
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):161-5. PubMed ID: 1633434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mood-stabilizing drugs in depression.
    Shelton RC
    J Clin Psychiatry; 1999; 60 Suppl 5():37-40; discussion 41-2. PubMed ID: 10192406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The current concept of augmentation of treatment efficiency with antidepressant medication].
    Damulin IV; Suvorova IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):106-112. PubMed ID: 26171486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lithium augmentation in antidepressant-resistant patients.
    Goodwin GM; Souza FG; Austin MP
    Br J Psychiatry; 1992 Jul; 161():128-9. PubMed ID: 1638316
    [No Abstract]   [Full Text] [Related]  

  • 57. The broad clinical spectrum of bipolar disorder: implications for research and practice.
    Smith D; Ghaemi S; Craddock N
    J Psychopharmacol; 2008 Jun; 22(4):397-400. PubMed ID: 18635715
    [No Abstract]   [Full Text] [Related]  

  • 58. Update on augmentation of antidepressant response in resistant depression.
    DeBattista C; Lembke A
    Curr Psychiatry Rep; 2005 Dec; 7(6):435-40. PubMed ID: 16318821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lithium augmentation of clomipramine.
    Feder R
    J Clin Psychiatry; 1988 Nov; 49(11):458. PubMed ID: 3141389
    [No Abstract]   [Full Text] [Related]  

  • 60. What happened to lithium? Antidepressant augmentation in clinical settings.
    Valenstein M; McCarthy JF; Austin KL; Greden JF; Young EA; Blow FC
    Am J Psychiatry; 2006 Jul; 163(7):1219-25. PubMed ID: 16816227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.